Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology ...

Following the launch of two new cancer tests—plus a third planned for before the end of 2025—Exact Sciences is nudging up its ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...

ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Former Queen's University spin-out using its unique AI-driven drug discovery engine to fight aggressive cancers ...

The world of oncology is evolving rapidly, with breakthrough technologies transforming the way cancer is treated and managed.

Chemical & Materials Engineering Assistant Professor Maryam Raeeszadeh-Sarmazdeh shares a few thoughts about her work and the ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the filing of its 2024 ...

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...